For Some Breast Cancer Survivors, Drug May Reduce Treatment-Related Joint Pain

Anne Li                                 1/15/17


A drug most commonly used to treat depression may also reduce joint pain in some women being treated for early-stage breast cancer, according to the results of a randomized clinical trial. After undergoing treatment for early-stage breast cancer, many postmenopausal women take drugs known as aromatase inhibitors to reduce the risk of the cancer returning. These drugs, however, can cause significant pain in women’s joints and muscles. The clinical trialExit Disclaimer showed that duloxetine (Cymbalta®), which is approved to treat depression and anxiety as well as fibromyalgia and nerve pain caused by diabetes, provided some relief from pain associated with aromatase inhibitors.


See original article at: https://www.cancer.gov/news-events/cancer-currents-blog/2017/duloxetine-breast-joint-pain


Post a comment